GSK - GSK Plc - ADR
Close
43.91
0.170 0.387%
Share volume: 3,129,062
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$43.74
0.17
0.39%
Summary score
54%
Profitability
63%
Dept financing
49%
Liquidity
51%
Performance
48%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 31-Dec-2019 - 31-Dec-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
16.23%
Return on assets
2.15%
Return on sales
10.13%
Return on invested capital
6.22%
Total debt ratio
81.25%
Debt ratio change over timeo
11.01%
Current Ratio
0.95%
Quick Ratio
0.7%
Cash Position Ratio
0.27%
Short-term ratios 31-Dec-2022 - 31-Dec-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
10.01%
Return on assets
3.05%
Return on sales
20.66%
Return on invested capital
7.03%
Total debt ratio
78.57%
Debt ratio change over timeo
13.92%
Current Ratio
0.92%
Quick Ratio
0.66%
Cash Position Ratio
0.29%
Last quarter ratios 31-Dec-2023
The data are presented for the financials results of the last quarter.
Return on equity
3.5%
Return on assets
2.21%
Return on sales
12.16%
Return on invested capital
2.42%
Total debt ratio
77.38%
Debt ratio change over time
30.97%
Current Ratio
0.88%
Quick Ratio
0.62%
Cash Position Ratio
0.25%
Performance ratios (change over 4 years) 31-Dec-2019 - 31-Dec-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
106.2%
Return on assets
-55.46%
Return on sales
814.54%
Return on invested capital
1.41%
Total debt ratio
1101.12%
Debt ratio change over time
11.01%
Current Ratio
12.8%
Quick Ratio
8.69%
Cash Position Ratio
3.21%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | GSK | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 16.23% | 20.69% | 17.34% | 7.9% |
| Return on assets | 2.15% | 4.16% | 8.21% | 3.23% |
| Return on sales | 10.13% | 28.16% | 41.18% | 25.36% |
| Return on invested capital | 6.22% | 9.72% | -219.55% | 7.62% |
| Profitability | 48% | 80% | 71% | 54% |
| Total debt ratio | 81.25% | 83.67% | 55.88% | 60.1% |
| Debt ratio change over time | 11.01% | -4.1% | -0.73% | -33.57% |
| Dept financing | 49% | 25% | 17% | 18% |
| Current Ratio | 0.92% | 1.1% | 0% | 1.14% |
| Quick Ratio | 0.66% | 0.86% | 0% | 0.9% |
| Cash Position Ratio | 0.29% | 0.15% | 0% | 0.49% |
| Liquididy | 47% | 54% | 57% | 75% |
| Short-term ratios | GSK | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 10.01% | 11.94% | 0% | 12.29% |
| Return on assets | 3.05% | 4.45% | 0% | 3.02% |
| Return on sales | 20.66% | 29.67% | 0% | 25.18% |
| Return on invested capital | 7.03% | 9.96% | 0% | 12.71% |
| Profitability | 69% | 94% | 0% | 88% |
| Total debt ratio | 78.57% | 80.64% | 0% | 60.17% |
| Debt ratio change over time | 13.92% | -40.42% | 0% | -162.47% |
| Dept financing | 49% | 25% | 0% | 19% |
| Current Ratio | 0.92% | 1.1% | 0% | 1.14% |
| Quick Ratio | 0.66% | 0.86% | 0% | 0.9% |
| Cash Position Ratio | 0.29% | 0.15% | 0% | 0.49% |
| Liquididy | 53% | 56% | 0% | 75% |